https://www.selleckchem.com/products/sop1812.html
ugh specificity to predict mortality or poor neurological outcome on their own and should only be additively used in clinical decision making.Ebola virus (EBOV), a member of the mononegaviral family Filoviridae, causes severe disease associated with high lethality in humans. Despite enormous progress in development of EBOV medical countermeasures, no anti-EBOV treatment has been approved. We designed an immunotoxin in which a single-chain variable region fragment of the EBOV glycoprotein-specific monoclonal antibody 6D8 was fused to the
Like
Comment
Share
